Más Información

Ningún gobierno extranjero puede entrar a nuestro territorio: Sheinbaum; aquí se topan con principios y el pueblo de México, dice

Cae en Sinaloa el hijo de "El Balta" Díaz, exconsuegro de "El Mayo" Zambada; fue arrestado en una taquería de Ahome

Ferroviaria Canadian Pacific Kansas City demanda a México; acusan que proyecto de trenes de pasajeros afecta sus inversiones

Ella es Columba López, la primera mujer al frente de la Sader; asume el cargo con "amor a la patria, la tierra y el campo", dice

Sheinbaum designa a Columba López como secretaria de Agricultura; Berdegué defenderá al campo mexicano rumbo a revisión del T-MEC

Delgado respalda a Ariadna Montiel rumbo a dirigencia de Morena; "su liderazgo nos conducirá a una jornada histórica en el 2027"
Kalaumari Mayoral Peña
, a student from the Monterrey Institute of Technology and Higher Education (ITESM) , Querétaro campus, is developing a chip that can detect and separate cancerous cells in the bloodstream with 90% efficiency.
The microfluid chip is part of Mayoral Peña’s doctoral project and works with a blood sample similar to the one obtained with a glucometer.
At first, the device will focus on detecting breast cancer, according to a press release issued by the university through their website .
One of the microchip’s most important traits is that it captures and analyzes cancer cells individually, which allows to gather valuable information for the patient’s diagnose and treatment.
“Conducting a thorough analysis of cancer cells by using new biotechnological tools will allow us to gather information that can help in the development of better treatments and diagnosic techniques,” said Mayoral in an interview.
Unlike conventional procedures that take cell samples and assess an average of the amount of cancer cells in the bloodstream, this hi-tech analysis takes into account small cancer cell clusters with a different profile, which are harder to detect otherwise.
The student clarified that he still didn’t have a parameter for effectiveness, though he expects the chip to be 90% effective during trials with cancerous cells.
The project has offered Mayoral Peña many opportunities to collaborate with both Mexican and foreign institutions, such as Harvard University .
dm
Noticias según tus intereses
[Publicidad]
[Publicidad]









